Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms

压力与人类干/祖细胞:生物行为机制

基本信息

项目摘要

ABSTRACT Our goal is to test a novel hypothesis in humans about the impact of chronic stress and stress-related biobehavioral processes on stem/progenitor cell biology. Although substantial progress has been made in understanding how stress becomes biologically embedded to produce long-term effects, crucial knowledge gaps remain. The processes implicated in biological embed- ding have been described primarily at the level of differentiated cells types that form tissues and organ systems. Based on the consideration that the long-term effects of stress can extend well beyond the lifespan of most differentiated cells, whose replenishment does not occur from already-differentiated ‘parent’ cells, but occurs from stem/progenitor cells, we advance the hypothesis that biological embedding of the effects of chronic stress may extend all the way down to the level of stem cells, to define fundamental aspects of their biology that determine the earliest vulnerabilities for common stress- and age-related disorders. We underscore the importance of studying fetal (newborn) stem cells, focus specifically on hematopoietic (HSCs) and mesenchymal stem/progenitor cells (MSCs), and on the functional capacity of their telomere and mitochondrial systems as our primary outcomes. We operationalize chronic stress using a composite biological measure of maternal allostatic load that incorporates the principal biomarkers of the gestational stress transmission pathway. Because stress responsivity is a key modulator of chronic stress effects, we additionally propose to characterize this phenotype in HSCs and MSCs via an in vitro oxidative stress [H2O2] challenge. We will conduct the proposed study in N=300 mother-child dyads; isolate and culture newborn HSCs and MSCs from umbilical cord blood and cord tissue, respectively; and perform cellular telomerase activity and high-resolution respirometry experiments to characterize telomere and mitochondrial functional capacity. Aim 1 will test the hypothesis that chronic stress exposure (allostatic load) is prospectively associated with reduced functional capacity of newborn HSC and MSC telomere and mitochondrial systems. Aim 2A will test the hypothesis that chronic stress exposure primes the stress responsivity phenotype of newborn HSCs and MSCs, and Aim 2B will determine whether antioxidant (resveratrol) pretreatment attenuates this effect. Both aims will include tests for effect modification by sex and key covariates of telomere and mitochondrial function. Aim 3 will elucidate the maternal sociodemographic, psychosocial, behavioral and biophysical determinants of variation in components of allostatic load that impact newborn HSC/MSC biology using state-of-the-art machine learning and prediction approaches. Aim 4 will establish a shared Biobank repository of HSC, MSC, cord blood, cord and placental tissue samples for future studies of molecular mechanisms (gene expression, epigenetic profiles) and in vitro differen- tiation. Significance and Impact: Our project will 1) define novel measures (and their norms) in human newborn stem cells that profile the earliest vulnerabilities for cell health and risk of age-related disorders; 2) broaden under- standing of novel cellular targets and molecular mechanisms underlying biological embedding of stress, that, in turn, may inform the development of personalized interventions; and 3) provide shared resources (human newborn stem cell, placenta, cord, and cord blood biobank).
摘要 我们的目标是在人类中测试一个关于慢性压力和压力相关的生物行为过程对 干/祖细胞生物学。尽管在理解压力如何从生物学上变成 但关键的知识差距依然存在。生物学中的过程- 已经主要在形成组织和器官系统的分化细胞类型的水平上描述了DING。基于 考虑到压力的长期影响可以远远超过大多数分化的生命周期, 细胞,其补充不是从已经分化的“亲本”细胞发生,而是从干/祖细胞发生 细胞,我们提出的假设,生物嵌入的慢性压力的影响可能会一直延伸到干细胞的水平 细胞,以确定其生物学的基本方面,确定常见的压力和年龄相关疾病的最早脆弱性。 我们强调研究胎儿(新生儿)干细胞的重要性,特别关注造血干细胞(HSC), 间充质干/祖细胞(MSC),并对他们的端粒和线粒体系统的功能能力,作为我们的 主要成果。我们使用母体非稳态负荷的复合生物学测量来操作慢性压力, 整合了妊娠应激传递途径的主要生物标志物。因为压力反应能力是 作为慢性应激效应的调节剂,我们还建议通过一种新的方法来表征HSC和MSC中的这种表型。 体外氧化应激[H2 O2]激发。我们将在N=300对母子中进行拟定研究;分离 分别从脐带血和脐带组织中培养新生HSCs和MSCs, 端粒酶活性和高分辨率呼吸测量实验表征端粒和线粒体功能 容量目的1将检验慢性应激暴露(非稳态负荷)与功能降低相关的假设。 新生HSC和MSC端粒和线粒体系统的能力。目标2A将检验慢性应激暴露 启动新生HSC和MSC的应激反应表型,Aim 2B将决定抗氧化剂(白藜芦醇) 预处理减弱了这种效应。这两个目标将包括测试性别和端粒的关键协变量的效应修饰, 线粒体功能目标3将阐明母亲的社会人口学、心理社会、行为和生物物理决定因素 使用最先进的机器学习,研究影响新生HSC/MSC生物学的非稳态负荷组分的变化, 预测方法。目的4建立HSC、MSC、脐带血、脐带和胎盘的共享生物库 组织样本,用于未来的分子机制研究(基因表达,表观遗传学概况)和体外生物学研究, 是的。意义和影响:我们的项目将1)定义人类新生儿的新措施(及其规范) 干细胞,概况细胞健康和年龄相关疾病的风险最早的脆弱性; 2)扩大下, 新的细胞靶点和应激生物学嵌入的分子机制,反过来, 可以为个性化干预措施的发展提供信息;以及3)提供共享资源(人类新生儿干细胞) 细胞、胎盘、脐带和脐带血生物库)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kristen Elizabeth Boyle其他文献

Kristen Elizabeth Boyle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kristen Elizabeth Boyle', 18)}}的其他基金

Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms
压力与人类干/祖细胞:生物行为机制
  • 批准号:
    10522469
  • 财政年份:
    2022
  • 资助金额:
    $ 65.07万
  • 项目类别:
BIOLOGICAL EMBEDDING OF SOCIAL DISADVANTAGE IN HUMAN STEM CELLS: IMPLICATIONS FOR HEALTH DISPARITIES
人类干细胞中社会劣势的生物嵌入:对健康差异的影响
  • 批准号:
    10710216
  • 财政年份:
    2022
  • 资助金额:
    $ 65.07万
  • 项目类别:
BIOLOGICAL EMBEDDING OF SOCIAL DISADVANTAGE IN HUMAN STEM CELLS: IMPLICATIONS FOR HEALTH DISPARITIES
人类干细胞中社会劣势的生物嵌入:对健康差异的影响
  • 批准号:
    10594741
  • 财政年份:
    2022
  • 资助金额:
    $ 65.07万
  • 项目类别:
Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humans
婴儿间充质干细胞的表观遗传编程:人类肥胖和糖尿病风险的机制
  • 批准号:
    10441451
  • 财政年份:
    2018
  • 资助金额:
    $ 65.07万
  • 项目类别:
Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humans
婴儿间充质干细胞的表观遗传编程:人类肥胖和糖尿病风险的机制
  • 批准号:
    10197911
  • 财政年份:
    2018
  • 资助金额:
    $ 65.07万
  • 项目类别:
Human Mesenchymal Stem Cells and the Epigenetic Programming of Obesity
人类间充质干细胞与肥胖的表观遗传编程
  • 批准号:
    9108960
  • 财政年份:
    2015
  • 资助金额:
    $ 65.07万
  • 项目类别:
Cellular Mechanisms for Insulin Resistance in Human Gestational Diabetes Mellitus
人类妊娠糖尿病胰岛素抵抗的细胞机制
  • 批准号:
    8229902
  • 财政年份:
    2011
  • 资助金额:
    $ 65.07万
  • 项目类别:
Cellular Mechanisms for Insulin Resistance in Human Gestational Diabetes Mellitus
人类妊娠糖尿病胰岛素抵抗的细胞机制
  • 批准号:
    8003061
  • 财政年份:
    2011
  • 资助金额:
    $ 65.07万
  • 项目类别:

相似国自然基金

基于语义理解的中文地址匹配关键技术研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于众源地址数据的标准地址集智能化构建方法研究
  • 批准号:
    n/a
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
面向空间语义建模与检索的城市地址图模型研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
新型智慧城市地名地址数据融合治理关键技术研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
基于SDN的动目标防御网络关键技术研究
  • 批准号:
    61702535
  • 批准年份:
    2017
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.07万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了